Navigation Links
Schering-Plough Reports Financial Results for First Quarter of 2008
Date:4/23/2008

any's plans; its strategies; its progress under the Action Agenda and anticipated timing regarding future performance of the Action Agenda; business prospects; anticipated growth; timing and level of savings achieved from the Productivity Transformation Program; prospective products or product approvals; trends in performance; anticipated timing of clinical trials and its impact on R&D spending; anticipated exclusivity periods; actions to enhance clinical, R&D, manufacturing and post-marketing systems; and the potential of products and trending in therapeutic markets, including the cholesterol market. Actual results may vary materially from the company's forward-looking statements, and there are no guarantees about the performance of Schering-Plough stock or Schering-Plough's business. Schering-Plough does not assume the obligation to update any forward-looking statement. A number of risks and uncertainties could cause results to differ materially from forward-looking statements, including, among other uncertainties, market viability of the company's (and the cholesterol joint venture's) marketed and pipeline products; market forces; economic factors such as interest rate and exchange rate fluctuations; the outcome of contingencies such as litigation and investigations including litigation and investigations relating to the ENHANCE clinical trial; product availability; patent and other intellectual property protection; current and future branded, generic or over-the-counter competition; the regulatory process (including product approvals, labeling and post-marketing actions); scientific developments relating to marketed products or pipeline projects; and media and societal reaction to such developments. For further details of these and other risks and uncertainties that may impact forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 1A, "Risk Factors" in the company's 2007 10-K/A.

Schering-Plough is an i
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
2. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
3. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
4. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
5. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
6. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
7. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
8. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
11. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Cayenne Medical, Inc., a privately held ... tissue reconstruction segment, announced the worldwide launch of ... the shoulder and extremities. The SureLock System provides ... method. The unique delivery eliminates manual tensioning that ... anchor displacement (also commonly know as anchor “creep”). ...
(Date:7/10/2014)... Understanding the need for better quality and ... gap that currently exists in this area, ChanTest has ... of validated ion channel and GPCR cell lines. ... ion channels control many critical physiological functions throughout the ... potential to treat a variety of human diseases. ...
(Date:7/10/2014)... July 10, 2014 OMICS Group’s 5th ... during 18-20 August, 2014 at Double Tree by Hilton ... recent developments in Analytical & Bioanalytical research methods only ... Speaking on this occasion, Dr. Srinubabu Gedela, MD of ... conference is a remarkable one in bringing a unique ...
(Date:7/10/2014)... , July 10, 2014 ... Dmitry Medvedev , presented Russia,s ... BIOCAD . The Company is developing a unique ... MabNext project BIOCAD develops a number of innovative drugs ... autoimmune diseases. The ceremony took place at the International ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2
... ... Hermes Biosciences and partnership with sanofi-aventis , ... Cambridge, MA (PRWEB) April 7, 2010 -- Merrimack Pharmaceuticals, Inc., ... for cancer and inflammation, today announced that William Sullivan has been promoted to Vice ...
... have found a way to turn a precision measurement device ... researchers adapted a device known as an optical frequency comb ... data operations that will be vital for future quantum computers. ... Review Letters and is described in a Viewpoint article ...
... ... to build and sell "Flexible Fuel" cars, as would be required by ... the impact of the stricter fuel efficiency standards announced today by President ... President,s announcement, advocates of energy independence challenged the President to show his ...
Cached Biology Technology:Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance 2Challenge President to Adopt Energy Measure with Double the Impact of Improved Auto Fuel Efficiency Standards at Fraction of the Cost 2
(Date:7/14/2014)... cases in Sierra Leone showed that about two-thirds of ... and nearly nine percent tested positive for Ebola virus. ... Emerging Infectious Diseases , demonstrates that Ebola virus has ... before the current outbreak. , First author Randal J. ... where he spent six weeks helping to set up ...
(Date:7/14/2014)... in the local environment manage much better in the ... environments. , A world without bees would be ... an additional 600 million to 1 billion Danish kroner ... bees making honey and pollinating a wide range of ... bees all over the world are under pressure from ...
(Date:7/14/2014)... consequence of aging? , Although it is widely thought ... risk of developing several common cancers decreases with age. ... decrease with age in the risk of developing certain ... puzzle was presented in a recent paper published in ... P. Brody of the Department of Biomedical Engineering at ...
Breaking Biology News(10 mins):Sierra Leone samples: Ebola evidence in West Africa in 2006 2Sierra Leone samples: Ebola evidence in West Africa in 2006 3Best for bees to be stay-at-homes 2
... in decks, utility poles and fences will likely leach ... groundwater, according to two research papers published online Wednesday. ... of Florida and Florida International University examined arsenic leaching ... real deck as well as from simulated landfills. , ...
... using MRI to detect magnetic probes of tiny iron ... time has successfully tracked immune-stimulating cells implanted into cancer ... the eight patients, MRI revealed that the implanted cells ... for treatment," says Jeff Bulte, Ph.D., an associate professor ...
... chicken when she crossed the road is less important that what ... , Organic arsenic is fed to poultry to prevent bacterial infections ... up by the tissue and the majority of it is excreted ... urine from under poultry houses -- is rich in nitrogen and ...
Cached Biology News:Researchers: Treated wood poses long-term threat 2Researchers: Treated wood poses long-term threat 3Magnetic probe successfully tracks implanted cells in cancer patients 2Magnetic probe successfully tracks implanted cells in cancer patients 3Geoscientists follow arsenic from chicken feed to streambeds 2
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
100 adhesive strips....
Request Info...
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Biology Products: